Abstract:Proinflammatory cytokines, elevated during inflammation caused by infection and/or autoimmune disorders, result in reduced clearance of drugs eliminated primarily by cytochrome P450 enzymes (CYPs). However, the effect of cytokines on hepatic drug transporter expression or activity has not been well-studied. Here, using plated human hepatocytes (PHHs; n = 3 lots), we investigated the effect of interleukin (IL)-6, IL-1 β , tumor necrosis factor- α (TNF- α ), and interferon- (IFN-), on the mRNA expression and activity of hepatic drug transporters. PHHs were incubated for 72 hours at their pathophysiologically relevant plasma concentrations, both individually (0.01, 0.1, 1, 10 ng/ml) or as a cocktail (i.e., when each was combined at 0.1 or 1 ng/ml). Following cytokine cocktail exposure (1 ng/ml), significant downregulation of mRNA expression of organic anion transporting polypeptide 1B1 (OATP1B1), OATP1B3, sodium/taurocholate cotransporting polypeptide (NTCP), breast cancer resistance protein (BCRP), P-glycoprotein (P-gp), multidrug and toxin extrusion protein 1, multidrug resistance proteins (MRP) 2, 3, and 4 was observed. While the mRNA expression of organic anion transporter (OAT) 2 and organic cation transporter (OCT) 1 was downregulated in two lots, it was upregulated in one lot. In agreement (mostly), the 1 ng/ml cytokine cocktail reduced OATP1B1/3, OATP2B1, OAT2, OCT1, and NTCP activity by 75%, 44%, 82%, 47%, and 80%, respectively. Interestingly, upregulation of OAT2 and OCT1 mRNA in one donor did not translate into the same directional change in activity. Although significant interlot variability was observed, in general, the above effects, using individual cytokines, could be attributed to IL-1 β , TNF- α , and IFN-. SIGNIFICANCE STATEMENT To date, this is the first comprehensive study to investigate the effect of four major proinflammatory cytokines, both individually and as a cocktail, on the mRNA expression and activity of human hepatic drug transporters. The data obtained can be used in the future to predict transporter-mediated drug clearance changes during inflammation through physiologically based pharmacokinetic modeling and simulation.

[A Review on Regulation of Drug Transporters During Inflammation].

Progress and Research about Effects of Inflammation on Expression and Activity of Drug Transporters

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Progress in Down-Regulation of Cytochrome P450 Enzyme Activities and Mechanisms During Inflammation

Changes of transporters expression and activity in rheumatoid arthritis

Dysregulation of Human Hepatic Drug Transporters by Proinflammatory Cytokines

Inflammation alters the expression pattern of drug transporters during Caco-2 cell stimulation and azoxymethane-induced colon tumorigenesis

The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4/NF-κB-Mediated Inflammation

Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells

[Modulation of Drug-Metabolizing Enzymes and Transporters under Hypoxia Environment].

Drug-induced inflammation: A review of literature.

Integrating Network Pharmacology and Traditional Chinese Medicine for Effective Inflammation Treatment

Bioresponsive Drug Delivery Systems for the Treatment of Inflammatory Diseases.

Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics–small molecule drug interactions

Molecular Pharmacology of Inflammation: Medicinal Plants As Anti-Inflammatory Agents

[Controlling Arachidonic Acid Metabolic Network: from Single- to Multi-Target Inhibitors of Key Enzymes].

An Overview of ABC and SLC Drug Transporter Gene Regulation

The role of gut microbiota and metabolites in regulating the immune response in drug-induced enteritis

Potential of natural products in inflammation: biological activities, structure–activity relationships, and mechanistic targets

Improving Curcumin Bioavailability: Targeted Delivery of Curcumin and Loading Systems in Intestinal Inflammation

Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells